Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 21-12-2015 | Practice Area: | Equity Capital Markets |
| Deal Title: | Alkem Laboratories Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Clifford Chance advised Nomura, JP Morgan, Axis Capital and Edelweiss as the lead managers on Alkem Laboratories Ltd's USD200 million Rule 144A/Reg S IPO. Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
|
||
| Financial Center: | Singapore | Value: | 100.01-500.00 |
| Advised Party: | Lead Managers | Law Firm | Clifford Chance |
| Issuer Jurisdiction- | India | Listing Jurisdiction- | India |
| Classification: |
Initial Public Offerings Bombay Stock Exchange |
Lawyer | Rahul Guptan |
